Pulmonary Arterial Hypertension Without effective treatment, pulmonary arterial
hypertension results in high morbidity and mortality. This review discusses the pathogenesis …

Risk stratification has gained an increasing role in predicting outcomes and guiding the
treatment of patients with pulmonary arterial hypertension (PAH). The most predictive …

Background Achievement of low-risk status is a treatment goal in pulmonary arterial
hypertension (PAH). Risk assessment often is performed using multiparameter tools, such …

As the world produces exabytes of data, there is a growing need to find new methods that
are more suitable for dealing with complex datasets. Artificial intelligence (AI) has significant …

Pulmonary hypertension is a complex disease with multiple causes, corresponding to
phenotypic heterogeneity and variable therapeutic responses. Advancing understanding of …

Background Several models have been developed to predict mortality in patients with
COVID-19 pneumonia, but only a few have demonstrated enough discriminatory capacity …

The right ventricle and its stress response is perhaps the most important arbiter of survival in
patients with pulmonary hypertension of many causes. The physiology of the …

Rationale: Predictors of adverse outcome in pulmonary hypertension (PH) are well
established; however, data that inform survival are lacking. Objectives: We aim to identify …

Background Stroke has multiple modifiable and nonmodifiable risk factors and represents a
leading cause of death globally. Understanding the complex interplay of stroke risk factors is …

Background Prognosis in pulmonary arterial hypertension (PAH) is closely related to
indexes of right ventricular function. A better understanding of their relationship may provide …